Where I see patients (2)
My reviews

"Fibrosis is a big problem. If you improve people and slow the progression of their disease...that’s a success."
Selected research
-
Protein biomarkers of disease progression in patients with systemic sclerosis associated interstitial lung disease.
Scientific reports
-
Idiopathic Pulmonary Fibrosis Is Associated with Common Genetic Variants and Limited Rare Variants.
American journal of respiratory and critical care medicine
-
Inhibition of MRTF activation as a clinically achievable anti-fibrotic mechanism for pirfenidone.
The European respiratory journal
4.9